1. Home
  2. TSHA vs MEC Comparison

TSHA vs MEC Comparison

Compare TSHA & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • MEC
  • Stock Information
  • Founded
  • TSHA 2019
  • MEC 1945
  • Country
  • TSHA United States
  • MEC United States
  • Employees
  • TSHA N/A
  • MEC N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • MEC Industrial Specialties
  • Sector
  • TSHA Health Care
  • MEC Industrials
  • Exchange
  • TSHA Nasdaq
  • MEC Nasdaq
  • Market Cap
  • TSHA 403.7M
  • MEC 370.6M
  • IPO Year
  • TSHA 2020
  • MEC 2019
  • Fundamental
  • Price
  • TSHA $2.00
  • MEC $17.21
  • Analyst Decision
  • TSHA Strong Buy
  • MEC Strong Buy
  • Analyst Count
  • TSHA 8
  • MEC 3
  • Target Price
  • TSHA $6.63
  • MEC $20.67
  • AVG Volume (30 Days)
  • TSHA 5.4M
  • MEC 87.6K
  • Earning Date
  • TSHA 11-13-2024
  • MEC 11-05-2024
  • Dividend Yield
  • TSHA N/A
  • MEC N/A
  • EPS Growth
  • TSHA N/A
  • MEC 53.85
  • EPS
  • TSHA N/A
  • MEC 0.59
  • Revenue
  • TSHA $9,915,000.00
  • MEC $608,880,000.00
  • Revenue This Year
  • TSHA N/A
  • MEC $0.34
  • Revenue Next Year
  • TSHA N/A
  • MEC $0.73
  • P/E Ratio
  • TSHA N/A
  • MEC $28.28
  • Revenue Growth
  • TSHA N/A
  • MEC 7.13
  • 52 Week Low
  • TSHA $1.19
  • MEC $11.07
  • 52 Week High
  • TSHA $4.32
  • MEC $23.02
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 41.45
  • MEC 47.98
  • Support Level
  • TSHA $1.97
  • MEC $16.42
  • Resistance Level
  • TSHA $2.72
  • MEC $17.49
  • Average True Range (ATR)
  • TSHA 0.23
  • MEC 0.47
  • MACD
  • TSHA -0.10
  • MEC 0.12
  • Stochastic Oscillator
  • TSHA 2.24
  • MEC 65.42

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

Share on Social Networks: